2-Amino-3- (methylamino) -Propanoic Acid (BMAA) in Cycad Flour:An Unlikely Cause of ALS & Parkinsonism-Dementia of Guam
Neurol 40:767-772, Duncan,M.W.,et al, 1990
Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist
AJNR 42:998-1007, Oldan, J.D.,et al, 2021
Amyotrophic Lateral Sclerosis
NEJM 377:162-172, Brown, R.H.,et al, 2017
Palliative Care and Neurology
Neurol 83:561-567, Boersma, I.,et al, 2014
Degenerative Diseases of the Nervous System, Amyotrophic Lateral Sclerosis
Adams & Victors Principles of Neurology, Chp 39, pg 1109, Ropper, A.H.,et al, 2014
The Spectrum of Mutations in Progranulin: A Collaborative Study Screening 545 Cases of Neurodegeneration
Arch Neurol 67:161-170,145, Yu,C.-E.,et al, 2010
A Large-Scale International Meta-Analysis of Paraoxonase Gene Polymorphisms in Sporadic ALS
Neurol 73:16-24,11, Wills,A.-M.,et al, 2009
What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008
Occurrence of Amyotrophic Lateral Sclerosis Among Gulf War Veterans
Neurol 61:742-749, Horner,R.D.,et al, 2003
Excess Incidence of ALS in Young Gulf War Veterans
Neurol 61:750-756, Haleyl,R.W., 2003
Familial Amyotrophic Lateral Sclerosis
Muscle Nerve 25:135-159, Hand,C.K. &Rouleau,G.A., 2002
Amyotrophic Lateral Sclerosis
NEJM 344:1688-1700, Rowland,L.P. & Shneider,N.A., 2001
Molecular Basis of the Neurodegenerative Disorders
NEJM 340:1970-1980, Martin,J.B., 1999
Risk of Amyotrophic Lateral Sclerosis & History of Physical Activity, A Population Study
Arch Neurol 55:201-206, Longstreth,W.T.,et al, 1998
Olfactory Dysfunction in Guamanian ALS,Parkinsonism,and Dementia
Neurol 51:1672-1677, Ahlskog,J.E.,et al, 1998
Familial Nature and Continuing Morbidity of the Amyotrophic Lateral Sclerosis-Parkinsonism Dementia Complex of Guam
Neurol 49:400-409, McGeer,P.L.,et al, 1997
Amyotrophic Lateral Sclerosis and Occupational History
Arch Neurol 53:730-733, Strickland,D.,et al, 1996
Motor Neuron Disease with Parkinsonism
Arch Neurol 53:987-991, Qureshi,A.I.,et al, 1996
Immunoassays Fail to Detect Antibodies Against Neuronal Calcium Channels in Amyotrophic Lateral Sclerosis Serum
Ann Neurol 40:695-700, 6911996., Arsac,C.,et al, 1996
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
Amyotrophic Lateral Sclerosis Patient Antibodies Label CA2+Channel a1 Subunit
Ann Neurol 35:164-171, 1311994., Fumiharu,K.,et al, 1994
Sequences Specific for Enterovirus Detected in Spinal Cord from Patients with Motor Neurone Disease
BMJ 308:1541-1543, Woodall,C.J.,et al, 1994
Superoxide Dismutase and ALS
Lancet 344:1651-1652, Orrell,R.W.&deBelleroche,J.S., 1994
Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994
Cell Culture Evidence for Neuronal Degeneration in ALS to Glutamate AMPA/Kainate Receptors
Lancet 341:265-268, Couratier,P.,et al, 1993
Spinal Fluid Cells and Protein in Amyotrophic Lateral Sclerosis
Arch Neurol 50:489-491, Norris,F.H.,et al, 1993
Evidence for a Dopaminergic Deficit in Sporadic Amyoptrophic Lateral Sclerosis on Positron Emission Scanning
Lancet 324:1016-1018, Takahashi,H.,et al, 1993
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
NEJM 326:1464-1468, 14931992., Rothstein,J.D.,et al, 1992
Serum Antibodies to L-Type Calcium Channels in Patients with Amyotrophic Lateral Sclerosis
NEJM 327:1721-1728, 17521992., Smith,R.G.,et al, 1992
Amyotrophic Lateral Sclerosis:A Case-Control Study Following Detection of a Cluster in a Small Wisconsin Community
Arch Neurol 47:38-41, Sienko,D.G.,et al, 1990
What Causes Motoneuron Disease?
Editorial, Lancet 336:1033-10351990., , 1990
Rising Mortality From Motoneuron Disease in the USA, 1962-84
Lancet 1:710-712, Lilienfeld,D.E.,et al, 1989
Amyotrophic Lateral Sclerosis, Recent Advances in Pathogenesis & Therapeutic Trials
Arch Neurol 45:189-202, Mitsumoto,H.,et al, 1988
Neurological Clues from Environmental Neurotoxins
BMJ 295:346-347, Martyn,C.N., 1987
Amytrophic Lateral Sclerosis:Part 2, Etiopathogenesis
Ann Neurol 18:419-431, Tandan,R.,et al, 1985
ALS & Pet Exposure
Neurol 35:717-720, Tarras,S.,et al, 1985
Inhibition of Terminal Axonal Sprouting by Serum From Patients with Amyotrophic Lateral Sclerosis
NEJM 311:933-939, Gurney,M.E.,et al, 1984
Familial Occurrence of Amyotrophic Lateral Sclerosis, Parkinsonism, & Dementia
Ann Neurol 16:642-648, Schmitt,H.P.,et al, 1984
Amyotrophic Lateral Sclerosis & Pet Exposure
NEJM 309:244-245, Schenkman,M.,et al, 1983
Syndromes of Amytrophic Lateral Sclerosis & Dementia:Relation to Transmissible Creutzfeldt-Jakob Disease
Ann Neurol 14:17-26, Salazar,A.M.,et al, 1983
Amyotrophic Lateral Sclerosis & its Association with Dementia, Parkinsonism & Other Neurological Disorders:A Review
Brain 104:217-247, Hudson,A.J., 1981
Cellular Immunity In Guamanians with Amyotrophic Lateral Sclerosis & Parkinsonism-Dementia
NEJM 299:680-685, Hoffman,P.M.,et al, 1978
Viruslike Particles in Amytrophic Lateral Sclerosis:Electron Microscopical Study of a Case
Ann Neurol 1:290, Pena,C.E., 1977
The Association of Parkinsonism & Motor Neuron Disease
Neurol 22:443, Brait,K., 1972
The Geography of Neurology
BMJ 2:506, Spillane,J.D., 1972
Clinical Cases-Dx:Functional Approach to Neuroanatomy pp 477-490 Earl Lawrence House
McGraw Hill 1967., , 1967